A scalable ultra-long-acting tenofovir phosphonate prodrug sustains HBV suppression.
Raut SS, Das S, Bybee G, Chava H, Ogunnaike M, Wang W, Pathania AS, Hanson BW, Le NTH, Cohen SM, Gendelman HE, Poluektova LY, Edagwa BJ, Osna NA.
Raut SS, et al.
Sci Adv. 2025 Aug;11(31):eadw2286. doi: 10.1126/sciadv.adw2286. Epub 2025 Aug 1.
Sci Adv. 2025.
PMID: 40749058
Free PMC article.